|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Howlader N, Noone AM, Krapcho M, Miller D,
Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, et al:
SEER Cancer Statistics Review, 1975–2016. Bethesda, MD: National
Cancer Institute; based on
November 2018 SEER data submission, posted to the SEER web site.
April. 2019
|
|
3
|
Alzahrani AS and Xing M: Impact of Iymph
node metastases identified on central neck dissection (CND) on the
recurrence of papillary thyroid cancer: Potential role of
BRAFV600E mutation in defining CND. Endocr Relat Cancer.
20:13–22. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carcangiu ML, Zampi G, Pupi A, Castagnoli
A and Rosai J: Papillary carcinoma of the thyroid. A
clinicopathologic study of 241 cases treated at the University of
Florence, Italy. Cancer. 55:805–828. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Albores-Saavedra J and Wu J: The many
faces and mimics of papillary thyroid carcinoma. Endocr Pathol.
17:1–18. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen X, Liu R and Xing M: A six-genotype
genetic prognostic model for papillary thyroid cancer. Endocr Relat
Cancer. 24:41–52. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Omry-Orbach G: Risk stratification in
differentiated thyroid cancer: An ongoing process. Rambam
Maimonides Med J. 7:e00032016. View Article : Google Scholar
|
|
9
|
Luster M, Clarke SE, Dietlein M, Lassmann
M, Lind P, Oyen WJ, Tennvall J and Bombardieri E; European
Association of Nuclear Medicine (EANM), : Guidelines for
radioiodine therapy of differentiated thyroid cancer. Eur J Nucl
Med Mol Imaging. 35:1941–1959. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Feng G, Ma HM, Huang HB, Li YW, Zhang P,
Huang JJ, Cheng L and Li GR: Overexpression of COL5A1 promotes
tumor progression and metastasis and correlates with poor survival
of patients with clear cell renal cell carcinoma. Cancer Manag Res.
11:1263–1274. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tschirdewahn S, Panic A, Püllen L, Harke
NN, Hadaschik B, Riesz P, Horváth A, Szalontai J, Nyirády P, Baba
HA, et al: Circulating and tissue IMP3 levels are correlated with
poor survival in renal cell carcinoma. Int J Cancer. 145:531–539.
2019.PubMed/NCBI
|
|
12
|
Gąsior-Perczak D, Kowalik A, Walczyk A,
Siołek M, Gruszczyński K, Pałyga I, Mikina E, Trybek T, Kopczyński
J, Mężyk R, et al: Coexisting germline CHEK2 and somatic
BRAFV600E mutations in papillary thyroid cancer and
their association with clinicopathological features and disease
course. Cancers (Basel). 11:17442019. View Article : Google Scholar
|
|
13
|
Cancer Genome Atlas Research Network, .
Integrated genomic characterization of papillary thyroid carcinoma.
Cell. 159:676–690. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao Y, Yu T, Chen L, Xie D, Wang F, Fu L,
Cheng C, Li Y, Zhu X and Miao G: A germline CHEK2 mutation in a
family with papillary thyroid cancer. Thyroid. 30:924–930. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tomczak K, Czerwińska P and Wiznerowicz M:
The Cancer Genome Atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn). 19:A68–A77. 2015.PubMed/NCBI
|
|
16
|
R Core Team: R: A language and environment
for statistical computing. Computing. 1:12–21. 2015.
|
|
17
|
Gong Y, Zou B, Chen J, Ding L, Li P, Chen
J, Chen J, Zhang B and Li J: Potential Five-MicroRNA signature
model for the prediction of prognosis in patients with Wilms tumor.
Med Sci Monit. 25:5435–5444. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fan Q and Liu B: Identification of a
RNA-Seq based 8-long non-coding RNA signature predicting survival
in esophageal cancer. Med Sci Monit. 22:5163–5172. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tian S, Meng G and Zhang W: A six-mRNA
prognostic model to predict survival in head and neck squamous cell
carcinoma. Cancer Manag Res. 11:131–142. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang J, Kong D, Cui Q, Wang K, Zhang D,
Yuan Q, Liao X, Gong Y and Wu G: Bioinformatic analysis and
identification of potential prognostic microRNAs and mRNAs in
thyroid cancer. PeerJ. 6:e46742018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Prislei S, Martinelli E, Zannoni GF,
Petrillo M, Filippetti F, Mariani M, Mozzetti S, Raspaglio G,
Scambia G and Ferlini C: Role and prognostic significance of the
epithelial-mesenchymal transition factor ZEB2 in ovarian cancer.
Oncotarget. 6:18966–18979. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhan HX, Xu JW, Wang L, Wu D, Zhang GY and
Hu SY: FoxQ1 is a novel molecular target for pancreatic cancer and
is associated with poor prognosis. Curr Mol Med. 15:469–477. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu H, Chen S, You Z, Xie C, Huang S and Hu
X: PFKFB4 negatively regulated the expression of histone
acetyltransferase GCN5 to mediate the tumorigenesis of thyroid
cancer. Dev Growth Differ. 62:129–138. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang L, Cai Y, Luo Y, Xiong D, Hou Z, Lv
J, Zeng F, Yang Y and Cheng X: JAZF1 suppresses papillary thyroid
carcinoma cell proliferation and facilitates apoptosis via
regulating TAK1/NF-κB pathways. Onco Targets Ther. 12:10501–10514.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu ST, Zhong Q, Chen RH, Han P, Li SB,
Zhang H, Yuan L, Xia TL, Zeng MS and Huang XM: CRLF1 promotes
malignant phenotypes of papillary thyroid carcinoma by activating
the MAPK/ERK and PI3K/AKT pathways. Cell Death Dis. 9:3712018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vecchio G, Parascandolo A, Allocca C,
Ugolini C, Basolo F, Moracci M, Strazzulli A, Cobucci-Ponzano B,
Laukkanen MO, Castellone MD and Tsuchida N: Human a-L-fucosidase-1
attenuates the invasive properties of thyroid cancer. Oncotarget.
8:27075–27092. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bertoni APS, Bracco PA, de Campos RP, Lutz
BS, Assis-Brasil BM, Meyer ELS, Saffi J, Braganhol E, Furlanetto TW
and Wink MR: Activity of ecto-5′-nucleotidase (NT5E/CD73) is
increased in papillary thyroid carcinoma and its expression is
associated with metastatic lymph nodes. Mol Cell Endocrinol.
479:54–60. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jendrzejewski JP, Liyanarachchi S, Nagy R,
Senter L, Wakely PE, Thomas A, Nabhan F, He H, Li W, Sworczak K, et
al: Papillary thyroid carcinoma: Association between germline DNA
variant markers and clinical parameters. Thyroid. 26:1276–1284.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Siołek M, Cybulski C, Gąsior-Perczak D,
Kowalik A, Kozak-Klonowska B, Kowalska A, Chłopek M, Kluźniak W,
Wokołorczyk D, Pałyga I, et al: CHEK2 mutations and the risk of
papillary thyroid cancer. Int J Cancer. 137:548–552. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wójcicka A, Czetwertyńska M, Świerniak M,
Długosińska J, Maciąg M, Czajka A, Dymecka K, Kubiak A, Kot A,
Płoski R, et al: Variants in the ATM-CHEK2-BRCA1 axis determine
genetic predisposition and clinical presentation of papillary
thyroid carcinoma. Genes Chromosomes Cancer. 53:516–523. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stein L, Rothschild J, Luce J, Cowell JK,
Thomas G, Bogdanova TI, Tronko MD and Hawthorn L: Copy number and
gene expression alterations in radiation-induced papillary thyroid
carcinoma from chernobyl pediatric patients. Thyroid. 20:475–487.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chang Z, Cai C, Han D, Gao Y, Li Q, Feng
L, Zhang W, Zheng J, Jin J, Zhang H and Wei Q: Anoctamin5 regulates
cell migration and invasion in thyroid cancer. Int J Oncol.
51:1311–1319. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tenbaum SP, Juenemann S, Schlitt T, Bernal
J, Renkawitz R, Muñoz A and Baniahmad A: Alien/CSN2 gene expression
is regulated by thyroid hormone in rat brain. Dev Biol.
254:149–160. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu S, Zhou HY, Deng SC, Deng SJ, He C, Li
X, Chen JY, Jin Y, Hu ZL, Wang F, et al: ASIC1 and ASIC3 contribute
to acidity-induced EMT of pancreatic cancer through activating
Ca2+/RhoA pathway. Cell Death Dis. 8:e28062017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ceder R, Haig Y, Merne M, Hansson A, Zheng
X, Roberg K, Nees M, Iljin K, Bloor BK, Morgan PR, et al:
Differentiation-promoting culture of competent and noncompetent
keratinocytes identifies biomarkers for head and neck cancer. Am J
Pathol. 180:457–472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang DL, Qu LW, Ma L, Zhou YC, Wang GZ,
Zhao XC, Zhang C, Zhang YF, Wang M, Zhang MY, et al: Genome-wide
identification of transcription factors that are critical to
non-small cell lung cancer. Cancer Lett. 434:132–143. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cui T, Yang L, Ma Y, Petersen I and Chen
Y: Desmocollin 3 has a tumor suppressive activity through
inhibition of AKT pathway in colorectal cancer. Exp Cell Res.
378:124–130. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liang L, Zeng JH, Qin XG, Chen JQ, Luo DZ
and Chen G: Distinguishable prognostic signatures of left- and
right-sided colon cancer: A study based on sequencing data. Cell
Physiol Biochem. 48:475–490. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lan Y, Xiao X, Luo Y, He Z and Song X:
FEZF1 is an independent predictive factor for recurrence and
promotes cell proliferation and migration in cervical cancer. J
Cancer. 9:3929–3938. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Burotto M, Chiou VL, Lee JM and Kohn EC:
The MAPK pathway across different malignancies: A new perspective.
Cancer. 120:3446–3456. 2015. View Article : Google Scholar
|
|
42
|
Nakagawa H, Hirata Y, Takeda K, Hayakawa
Y, Sato T, Kinoshita H, Sakamoto K, Nakata W, Hikiba Y, Omata M, et
al: Apoptosis signal-regulating kinase 1 inhibits
hepatocarcinogenesis by controlling the tumor-suppressing function
of stress-activated mitogen-activated protein kinase. Hepatology.
54:185–195. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li S, Yin Y and Yu H: Genetic expression
profile-based screening of genes and pathways associated with
papillary thyroid carcinoma. Oncol Lett. 16:5723–5732.
2018.PubMed/NCBI
|
|
44
|
Chen S, Fan X, Gu H, Zhang L and Zhao W:
Competing endogenous RNA regulatory network in papillary thyroid
carcinoma. Mol Med Rep. 18:695–704. 2018.PubMed/NCBI
|
|
45
|
Puxeddu E and Moretti S: Clinical
prognosis in BRAF-mutated PTC. Arq Bras Endocrinol Metabol.
51:736–747. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu M, Yuan H, Li X, Liao Q and Liu Z:
Identification of a five-gene signature and establishment of a
prognostic nomogram to predict progression-free interval of
papillary thyroid carcinoma. Front Endocrinol (Lausanne).
10:7902019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cao R, Wu Q, Li Q, Yao M and Zhou H: A
3-mRNA-based prognostic signature of survival in oral squamous cell
carcinoma. PeerJ. 7:e73602019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cai J, Tong Y, Huang L, Xia L, Guo H, Wu
H, Kong X and Xia Q: Identification and validation of a potent
multi-mRNA signature for the prediction of early relapse in
hepatocellular carcinoma. Carcinogenesis. 40:840–852. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Xie X, Wang J, Shi D, Zou Y, Xiong Z, Li
X, Zhou J, Tang H and Xie X: Identification of a 4-mRNA
metastasis-related prognostic signature for patients with breast
cancer. J Cell Mol Med. 23:1439–1447. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Guo W, Chen X, Zhu L and Wang Q: A
six-mRNA signature model for the prognosis of head and neck
squamous cell carcinoma. Oncotarget. 8:94528–94538. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chuang MK, Chiu YC, Chou WC, Hou HA, Tseng
MH, Kuo YY, Chen Y, Chuang EY and Tien HF: An mRNA expression
signature for prognostication in de novo acute myeloid leukemia
patients with normal karyotype. Oncotarget. 6:39098–39110. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bao ZS, Li MY, Wang JY, Zhang CB, Wang HJ,
Yan W, Liu YW, Zhang W, Chen L and Jiang T: Prognostic value of a
nine-gene signature in glioma patients based on mRNA expression
profiling. CNS Neurosci Ther. 20:112–118. 2014. View Article : Google Scholar : PubMed/NCBI
|
